Literature DB >> 26093619

Genetic imprinting suggested by maternal DNA methylation in CNS hemangioblastoma with clinical phenotypes of VHL disease.

Dexuan Ma1, Ying Wang1, Liangfu Zhou2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26093619     DOI： 10.1007/s11060-015-1852-8

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  3 in total

Review 1.  Cancer epigenetics comes of age.

Authors:  P A Jones; P W Laird
Journal:  Nat Genet       Date:  1999-02       Impact factor: 38.330

2.  Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets.

Authors:  Laura J Rush; Aparna Raval; Pauline Funchain; Amy J Johnson; Lisa Smith; David M Lucas; Melania Bembea; Te-Hui Liu; Nyla A Heerema; Laura Rassenti; Sandya Liyanarachchi; Ramana Davuluri; John C Byrd; Christoph Plass
Journal:  Cancer Res       Date:  2004-04-01       Impact factor: 12.701

Review 3.  DNA methyltransferase inhibitors and their emerging role in epigenetic therapy of cancer.

Authors:  Agnieszka Gnyszka; Zenon Jastrzebski; Sylwia Flis
Journal:  Anticancer Res       Date:  2013-08       Impact factor: 2.480
  3 in total
  1 in total

1.  The Expression of VHL (Von Hippel-Lindau) After Traumatic Spinal Cord Injury and Its Role in Neuronal Apoptosis.

Authors:  Jie Hao; Xiaoqing Chen; Ting Fu; Jie Liu; Mingchen Yu; Wei Han; Shuang He; Rong Qian; Feng Zhang
Journal:  Neurochem Res       Date:  2016-06-21       Impact factor: 3.996
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.